Skip to content

Mirion Technologies MIR Change in Other Liabilities

Change in Other Liabilities at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$84K-86.9%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$33K-232%

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's change in other liabilities?
Mirion Technologies (MIR) reported change in other liabilities of $1.8M in Q1 2026.
How has Mirion Technologies's change in other liabilities changed year-over-year?
Mirion Technologies's change in other liabilities increased by 148.6% year-over-year, from -$3.7M to $1.8M.
What is the long-term trend for Mirion Technologies's change in other liabilities?
Over 2 years (2022 to 2024), Mirion Technologies's change in other liabilities has grown at a -61.7% compound annual growth rate (CAGR), from -$3.4M to $500K.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.